Semiconductor company MintNeuro announced a $5 million investment round on October 7, 2026, to scale its specialized chip platform for neural devices and brain-computer interfaces.
Funding Details
The investment round was led by Odyssey Ventures, with participation from 33East, JSK Investments and Alumni Ventures. The round also included returning investment from Empirical Ventures, Jumpspace Ventures and early investors.
MintNeuro will use the $5 million to grow its engineering and commercial teams, bring its products to market, support customers and strengthen its presence in the US alongside its UK and European base.
Technology and Partnerships
MintNeuro builds modular semiconductor platforms purpose-built for neural sensing, signal processing and stimulation. The company has already delivered working silicon and reached integration milestones with partners including Motif Neurotech and Amber Therapeutics.
Dorian Haci, co-founder and CEO of MintNeuro, stated that the funding moves the company from technology validation to commercial scale-up. Professor Tim Denison serves as the chair of MintNeuro.
Key facts and where they come from
- MintNeuro raised a $5 million investment round to drive its commercial scale-up.
MintNeuro, a semiconductor company building specialised chips for neural devices from implants to wearables, today announces a $5 million investment round to drive its commercial scale-up.
- The funding round was led by Odyssey Ventures.
The round was led by Odyssey Ventures, with participation from 33East, JSK Investments and Alumni Ventures, and returning investment from Empirical Ventures, Jumpspace Ventures and early investors.
- MintNeuro has reached key integration milestones with partners including Motif Neurotech and Amber Therapeutics.
MintNeuro has already delivered working silicon and reached key integration milestones with research and development partners, including Motif Neurotech and Amber Therapeutics.
Read the original from Company press releases (PR Newswire) →